Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Bone resorption is solely mediated by osteoclasts. Therefore, a pure osteoclast population is of high interest for the investigation of biological aspects of the osteoclasts, such as the direct effect of growth factors and hormones, as well as for testing and characterizing inhibitors of bone resorption. We have established a pure, stable, and reproducible system for purification of human osteoclasts from peripheral blood. We isolated CD14-positive (CD14+) monocytes using anti-CD14-coated beads. After isolation, the monocytes are differentiated into mature osteoclasts by stimulation with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappaB ligand (RANKL). Osteoclast formation was only observed in the CD14+ population, not in the CD14- population, and only in the presence of both M-CSF and RANKL, confirming that the CD14+ system is a pure population of osteoclast precursors. No expression of osteoclast markers was observed in the absence of RANKL, whereas RANKL dose-dependently induced the expression of cathepsin K, tartrate-resistant acid phosphatase (TRACP), and matrix metallo proteinase (MMP)-9. Furthermore, morphological characterization of the cells demonstrated that actin rings were only formed in the presence of RANKL. Moreover, the osteoclasts were capable of forming acidic resorption lacunae, and inhibitors of lysosomal acidification attenuated this process. Finally, we measured the response to known bone resorption inhibitors, and found that the osteoclasts were sensitive to these and thereby provided a robust and valid method for interpretation of the effect of antiresorptive compounds. In conclusion, we have established a robust assay for developing osteoclasts that can be used to study several biological aspects of the osteoclasts and which in combination with the resorption marker CTX-I provides a useful tool for evaluating osteoclast function in vitro.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MOs stimulated with RANKL and M-CSF generate functional OCs [27], which degrade bone and express OC markers [28].”
From PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation (2013) · cites this paper as [28]
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
Bowman, E. J., Siebers, A., & Altendorf, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7972 · Cited by 1,784
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
(2020) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,683
Principles of Bone Biology: By Bilezikian, Raisz and Rodan. Academic Press, London, U.K., 1996
Compston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,370
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Research works printed but not linked: 7
- GR Mundy, 1996, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 16
- T Suda, 1996, Principles of Bone Biology, 87
- R Baron, 1986, Am J Pathol, 122, 363
- K Väänänen, 1996, Principles of Bone Biology, 103
- SC Manolagas, 2000, Endocr Rev, 21, 115
- M Horton, 1990, J Exp Pathol, 71, 741
- Y Okada, 1995, Lab Invest, 72, 311
Cited by
Osteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 563
“apy, and expanded stem cells in transplant recipients (36, 109).”
BackgroundHenriksen, K., Bollerslev, J., Everts, V., & Karsdal, M. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0006 · Cited by 230
Self-citationde la Rica, L., Rodríguez-Ubreva, J., García, M., Islam, A. B., Urquiza, J. M., Hernando, H., Christensen, J., Helin, K., Gómez-Vaquero, C., & Ballestar, E. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r99 · Cited by 211
“MOs stimulated with RANKL and M-CSF generate functional OCs [27], which degrade bone and express OC markers [28].”
MiR-503 Regulates Osteoclastogenesis via Targeting RANK
Chen, C., Cheng, P., Xie, H., Zhou, H.-D., Wu, X.-P., Liao, E.-Y., & Luo, X.-H. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2032 · Cited by 214
“CD14þ peripheral blood mononuclear cells (PBMCs) serve as early progenitors of osteoclasts and are related to the pathophysiology of osteoporosis.((6,7)) Recent research revealed osteoclast formation in the presence of both macrophage colony‐stimulating factor (M‐CSF) and receptor activator of nuclear factor‐kB ligand…”
BackgroundMethodCheng, P., Chen, C., He, H.-B., Hu, R., Zhou, H.-D., Xie, H., Zhu, W., Dai, R.-C., Wu, X.-P., Liao, E.-Y., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1845 · Cited by 195
“PBMCs were isolated from buffy coats (Duo-Add blood bags; Baxter, Deerfield, IL, USA) using Ficoll-Paque (Amersham Pharmacia Biotech, Roosendaal, Netherlands) as described.((11)) Before further purification, granulocyte contamination was reduced to <1% by a second Ficoll-Paque separation step.”
BackgroundMethodInfluentialHopwood, B., Tsykin, A., Findlay, D. M., & Fazzalari, N. L. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2301 · Cited by 188
“CD14-deficient mice have increased bone mass [ 106 ,107]”
BackgroundJi, J.-D., Park-Min, K.-H., Shen, Z., Fajardo, R. J., Goldring, S. R., McHugh, K. P., & Ivashkiv, L. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900072 · Cited by 157
“esis in a standard, validated culture system (27).”
BackgroundGrigoriadis, A. E., Kennedy, M., Bozec, A., Brunton, F., Stenbeck, G., Park, I.-H., Wagner, E. F., & Keller, G. M. (2010) · Blood · doi:10.1182/blood-2009-07-234690 · Cited by 151
Sadowska, J. M., Wei, F., Guo, J., Guillem-Marti, J., Lin, Z., Ginebra, M.-P., & Xiao, Y. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.057 · Cited by 137
“For instance, no actin rings were observed in the multinucleated RAW cells (Figure 5C, right graph), a morphological feature of osteoblastic-like cells through which they create sealed regions that can be subjected to acidic resorption [70], Likewise, no signs of degradation were found in the CaP substrates (Figure 5C…”
BackgroundKarsdal, M. A., Henriksen, K., Leeming, D. J., Mitchell, P., Duffin, K., Barascuk, N., Klickstein, L., Aggarwal, P., Nemirovskiy, O., Byrjalsen, I., et al. (2009) · Biomarkers · doi:10.1080/13547500902777608 · Cited by 135
“In addition, in in vitro resorption experiments the CTX-I release is sensitive to inhibitors of bone resorption and can be used to dynamically monitor resorption inhibition occurring while the culture is ongoing (Sorensen et al. 2007a, b, Henriksen et al. 2004, 2005, Karsdal et al. 2005).”
BackgroundSelf-citationYao, W., Cheng, Z., Pham, A., Busse, C., Zimmermann, E. A., Ritchie, R. O., & Lane, N. E. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23954 · Cited by 128
“The coefficients of variation for interassay and intraassay measurements were 10% for all assays and were similar to the manufacturers’ reference values (20,30,31).”
ResultPark‐Min, K., Ji, J.-D., Antoniv, T. T., Reid, A. C., Silver, R. B., Humphrey, M. B., Nakamura, M. C., & Ivashkiv, L. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804165 · Cited by 130
Therapeutic potentials and modulatory mechanisms of fatty acids in bone
Bao, M., Zhang, K., Wei, Y., Hua, W., Gao, Y., Li, X., & Ye, L. (2019) · Cell Proliferation · doi:10.1111/cpr.12735 · Cited by 133
Osteoimmunology: cytokines and the skeletal system
Lee, S., Kim, T. S., Choi, Y., & Lorenzo, J. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.7.495 · Cited by 128
“In human peripheral blood, RANK osteoclast precursors were identified using CD14 expression and the lack of CD16 expression (15-17).”
Karsdal, M. A., Woodworth, T., Henriksen, K., Maksymowych, W. P., Genant, H., Vergnaud, P., Christiansen, C., Schubert, T., Qvist, P., Schett, G., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3280 · Cited by 114
Self-citationMammoli, F., Castiglioni, S., Parenti, S., Cappadone, C., Farruggia, G., Iotti, S., Davalli, P., Maier, J. A. M., Grande, A., & Frassineti, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020385 · Cited by 115
“In this regard, a crucial role might be played by the musculoaponeurotic fibrosarcoma oncogene homolog B (MAFB) and transcription factor binding to immunoglobulin heavy constant mu (IGHM) enhancer 3 (TFE3) transcription factors, based on their demonstrated involvement in VD3 response, as well as in osteoclast differen…”
BackgroundResultXia, Y., Inoue, K., Du, Y., Baker, S. J., Reddy, E. P., Greenblatt, M. B., & Zhao, B. (2022) · Nature Communications · doi:10.1038/s41467-022-31475-1 · Cited by 132
A 3D in vitro bone organ model using human progenitor cells
Papadimitropoulos, A., Scherberich, A., Güven, S., Theilgaard, N., Crooijmans, H., Santini, F., Scheffler, K., Zallone, A. Z., & Martín, I. (2011) · European Cells and Materials · doi:10.22203/ecm.v021a33 · Cited by 117
The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts
ten Harkel, B., Schoenmaker, T., Picavet, D. I., Davison, N. L., de Vries, T. J., & Everts, V. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139564 · Cited by 103
“It has been shown that resorption depends on the organization of F-actin structures (actin rings) into a sealing zone and that this structure is required for the formation of a resorption area [33,34].”
BackgroundMurata, K., Fang, C., Terao, C., Γιαννοπούλου, Ε., Lee, Y. J., Lee, M. J., Mun, S. H., Bae, S., Qiao, Y., Yuan, R., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.018 · Cited by 101
“We used nonproliferating human bloodderived macrophages as osteoclast precursors (OCPs), which offers the advantages of studying osteoclastogenesis separately from effects on proliferation and of using cells directly relevant for human diseases (Sørensen et al., 2007).”
Mörmann, M., Thederan, M., Nackchbandi, I., Giese, T., Wagner, C., & Hänsch, G. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.04.022 · Cited by 100
Henriksen, K., & Karsdal, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809847-9.00001-5 · Cited by 105
Self-citationKarsdal, M. A., Henriksen, K., Bay-Jensen, A. C., Molloy, B., Arnold, M., John, M. R., Byrjalsen, I., Azria, M., Riis, B. J., Qvist, P., et al. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010372625 · Cited by 87
Self-citationKalliolias, G. D., Zhao, B., Triantafyllopoulou, A., Park‐Min, K., & Ivashkiv, L. B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27200 · Cited by 87
“As expected from previous observations (44), culture of human CD14 cells with M-CSF plus RANKL induced differentiation of large, multinucleated TRAP cells, which became readily apparent within 5 days after the addition of RANKL (Figures 1A and B).”
ResultFang, C., Qiao, Y., Mun, S. H., Lee, M. J., Murata, K., Bae, S., Zhao, B., Park‐Min, K., & Ivashkiv, L. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501466 · Cited by 85
“We tested the effects of the selective EZH2 inhibitor GSK126 on osteoclast differentiation using human blood–derived OCPs, which are postmitotic cells thought to correspond to circulating quiescent OCPs that migrate to sites of bone erosion and differentiate into osteoclasts (17).”
BackgroundMethodKarsdal, M. A., Byrjalsen, I., Bay‐Jensen, A., Henriksen, K., Riis, B., & Christiansen, C. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-125 · Cited by 75
“Calcitonin, a 32-amino-acid peptide, which possesses approved anti-resorptive abilities [26-32], has been shown to have positive effects on both osteoclasts and chondrocytes [33].”
BackgroundSelf-citationKarsdal, M. A., Henriksen, K., Arnold, M., & Christiansen, C. (2008) · BioDrugs · doi:10.2165/00063030-200822030-00001 · Cited by 85
Self-citationOsteoclasts—Key Players in Skeletal Health and Disease
Novack, D. V., & Mbalaviele, G. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0011-2015 · Cited by 88
“While early committed OC precursors express TRAP (12) and αvβ5 integrin (13), late precursors and fully differentiated OC up-regulate cathepsin K (14, 15), calcitonin receptor (16), OC-associated receptor (OSCAR) (17) and αvβ3 integrin (18, 19).”
BackgroundLöfvall, H., Newbould, H., Karsdal, M. A., Dziegiel, M. H., Richter, J., Henriksen, K., & Thudium, C. S. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1564-5 · Cited by 75
“were generated as previously described [37, 38] from the peripheral blood of anonymized blood donors obtained from a blood bank.”
BackgroundSelf-citationCalcitonin Affects Both Bone and Cartilage: A Dual Action Treatment for Osteoarthritis?
KARSDAL, M. A., SONDERGAARD, B. C., ARNOLD, M., & CHRISTIANSEN, C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.041 · Cited by 70
Self-citationDoi, K., Murata, K., Ito, S., Suzuki, A., Terao, C., Ishie, S., Umemoto, A., Murotani, Y., Nishitani, K., Yoshitomi, H., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42074 · Cited by 74
“First, we tested the effects of LSD inhibition on osteoclast differentiation using human blood–derived OCPs, a strategy that provides the following advantages: the effects of the inhibitor on osteoclastogenesis can be studied separately from its effects on cell proliferation, and cells directly relevant for human dise…”
MethodHu, L., Lind, T., Sundqvist, A., Jacobson, A., & Melhus, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013305 · Cited by 71
“monocytes were carried out as described previously”
Veidal, S. S., Vassiliadis, E., Barascuk, N., Zhang, C., Segovia-Silvestre, T., Klickstein, L., Larsen, M. R., Qvist, P., Christiansen, C., Vainer, B., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02309.x · Cited by 66
Self-citationBernhardt, A., Thieme, S., Domaschke, H., Springer, A., Rösen‐Wolff, A., & Gelinsky, M. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32856 · Cited by 64
Mukai, T., Ishida, S., Ishikawa, R., Yoshitaka, T., Kittaka, M., Gallant, R., Lin, Y., Rottapel, R. K., Brotto, M., Reichenberger, E., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2295 · Cited by 72
“CD14þ monocytes, which have the potential to differentiate into osteoclasts,((44,45)) were also present (Fig.”
BackgroundHansen, M. S., Madsen, K., Price, M. L., Søe, K., Omata, Y., Zaiss, M. M., Gorvin, C. M., Frost, M., & Rauch, A. (2024) · Bone Research · doi:10.1038/s41413-023-00312-6 · Cited by 68
Osteoclast Fusion is Based on Heterogeneity Between Fusion Partners
Hobolt-Pedersen, A.-S., Delaissé, J.-M., & Søe, K. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9864-5 · Cited by 61
“Membrane-associated DCSTAMP is well documented to be a marker of early OC differentiation stages [26, 29], while CatK is a marker for rather late stages [30].”
BackgroundNielsen, R. H., Bay‐Jensen, A., Byrjalsen, I., & Karsdal, M. A. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.01.008 · Cited by 61
Self-citationKasonga, A. E., Deepak, V., Kruger, M. C., & Coetzee, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125145 · Cited by 63
“CTSK, TRAP and MMP-9 are all proteins that affect resorption [40].”
BackgroundChavassieux, P., Karsdal, M. A., Segovia‐Silvestre, T., Neutzsky-Wulff, A. V., Chapurlat, R. D., Boivin, G., & Delmas, P. D. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080231 · Cited by 65
“Separation and differentiation of CD14 monocytes: CD14 monocytes were isolated from peripheral blood from the pycnodysostosis patient and compared with that of three healthy sex- and aged-matched controls by CD14 magnetic cell sorting, as previously described.((15)) Briefly, the blood was layered on top of Ficoll-Paqu…”
MethodSelf-citationEffect of interleukin‐32γ on differentiation of osteoclasts from CD14+ monocytes
Kim, Y., Lee, C., Oh, J. S., Kim, S., Kim, K., & Yoo, B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27197 · Cited by 63
Park-Min, K.-H., Lee, E. Y., Moskowitz, N. K., Lim, E., Lee, S.-K., Lorenzo, J. A., Huang, C., Melnick, A. M., Purdue, P. E., Goldring, S. R., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1739 · Cited by 53
“We tested the effects of CD11b ligation on osteoclast differentiation using a validated culture system in which primary human blood-derived monocytes differentiate into osteoclasts.((33)) Treatment with Fb nearly completely and significantly (p< 0.”
MethodReduced miR-144-3p expression in serum and bone mediates osteoporosis pathogenesis by targeting RANK
Wang, C., He, H., Wang, L., Jiang, Y. Y., & Xu, Y. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0243 · Cited by 54
MEF2C regulates osteoclastogenesis and pathologic bone resorption via c-FOS
Fujii, T., Murata, K., Mun, S. H., Bae, S., Lee, Y. J., Pannellini, T., Kang, K., Oliver, D., Park‐Min, K., & Ivashkiv, L. B. (2021) · Bone Research · doi:10.1038/s41413-020-00120-2 · Cited by 61
“RESULTS MEF2C is a positive regulator of human osteoclastogenesis To identify the role of MEF2C in human osteoclast differentiation, we used human blood-derived osteoclast precursor cells (OCPs), which are relevant to human diseases.(24,25) Although the expression of MEF2C mRNA and protein in OCPs was diminished by RA…”
MethodInduction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis
Šućur, A., Katavić, V., Kelava, T., Jajić, Z., Kovačić, N., & Grčević, D. (2014) · International Orthopaedics · doi:10.1007/s00264-014-2386-y · Cited by 54
“vial fluid from arthritic patients [47–57].”
Zhang, Z., & Shively, J. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013985 · Cited by 54
“. Osteoclast were differentiated from monocytes in the presence of RANKL and M-CSF (both at 25 ng/mL)”
Karsdal, M., Byrjalsen, I., Riis, B., & Christiansen, C. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-12 · Cited by 50
“Binding of calcitonin to the calcitonin receptor on osteoclasts results in a reduction in a raid bone resorption [ 3- 5 ]. Salmon calcitonin is among to most potent calcitonins, and belongs to the teleost/avian family[1].”
Self-citationCLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis
Huang, Y.-L., Chen, S.-T., Liu, R.-S., Chen, Y., Lin, C.-Y., Huang, C., Shu, P., Liao, C., & Hsieh, S.-L. E. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1409-0 · Cited by 48
Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes
Barascuk, N., Skjøt‐Arkil, H., Register, T. C., Larsen, L., Byrjalsen, I., Christiansen, C., & Karsdal, M. A. (2010) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-10-19 · Cited by 47
“Finally, the cells were resuspended in phenol-red free alpha-MEM containing 10% serum, 100 units/ml penicillin and 100 μg/ml streptomycin, as previously described[20,33].”
BackgroundMethodSelf-citationThe immunophenotype of osteoclasts and macrophage polykaryons
Maggiani, F., Forsyth, R. G., Hogendoorn, P. C. W., Krenács, T., & Athanasou, N. A. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2011.090852 · Cited by 46
Li, M., Luo, R., Yang, W., Zhou, Z., & Li, C. (2019) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-019-00344-5 · Cited by 45
Lowry, M. B., Guo, C., Borregaard, N., & Gombart, A. F. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.004 · Cited by 46
Ion Transporters Involved in Acidification of the Resorption Lacuna in Osteoclasts
Henriksen, K., Sørensen, M. G., Jensen, V. K., Dziegiel, M. H., Nosjean, O., & Karsdal, M. A. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9168-8 · Cited by 47
“We evaluated inhibitors of V-ATPase and ClC-7, which both are highly expressed; and these inhibitors blocked resorption by attenuating acidification of the resorption lacuna, in alignment with previous data [15, 17, 31].”
ResultSelf-citationDirect Inhibition of Human RANK+ Osteoclast Precursors Identifies a Homeostatic Function of IL-1β
Lee, B., Kim, T.-H., Jun, J.-B., Yoo, D.-H., Woo, J.-H., Choi, S. J., Lee, Y. H., Song, G. G., Sohn, J., Park-Min, K.-H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001591 · Cited by 44
“We examined the effects of IL-1b on human osteoclastogenesis using a standard, validated system of human osteoclast differentiation (18).”
MethodDendritic Cell-Mediated In Vivo Bone Resorption
Maitra, R., Follenzi, A., Yaghoobian, A., Montagna, C., Merlin, S., Cannizzo, E. S., Hardin, J., COBELLI, N. J., Stanley, E. R., & Santambrogio, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903560 · Cited by 45
“Multiple focal planes (13) were acquired to ensure that signals on different focal planes were included.”
BackgroundmiR-140-3p aggregates osteoporosis by targeting PTEN and activating PTEN/PI3K/AKT signaling pathway
Yin, R., Jiang, J., Deng, H., Wang, Z., Gu, R., & Wang, F. (2020) · Human Cell · doi:10.1007/s13577-020-00352-8 · Cited by 46
Obitsu, S., Ahmed, N., Nishitsuji, H., Hasegawa, A., Nakahama, K., Morita, I., Nishigaki, K., Hayashi, T., Masuda, T., & Kannagi, M. (2009) · Archives of Virology · doi:10.1007/s00705-009-0472-z · Cited by 41
“monocytes [29] , we examined expression of ACE2 on the surface of CD14 ?”
BackgroundKylmäoja, E., Nakamura, M., Turunen, S., Patlaka, C., Andersson, G. N., Lehenkari, P. P., & Tuukkanen, J. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00780 · Cited by 47
“This is in line with the concept of the circulating osteoclast precursors [10, 11, 12, 13] and the fact that the majority of monocytes in PB are the classical monocytes, which are the main osteoclast precursors [20, 21, 22, 23, 24, 25, 26, 27].”
BackgroundResultKasonga, A. E., Kruger, M. C., & Coetzee, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071798 · Cited by 41
“PPARs are Expressed in CD14+ Monocytes To test whether PPARs are expressed in differentiating CD14+ monocytes, cells were exposed to RANKL and M-CSF for 1, 7 or 14 days before RNA was extracted.”
BackgroundInfluentialGeneration of Human Osteoclasts from Peripheral Blood
Henriksen, K., Karsdal, M. A., Taylor, A., Tosh, D., & Coxon, F. P. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-415-5_11 · Cited by 40
Self-citationSkjøt‐Arkil, H., Barascuk, N., Register, T. C., & Karsdal, M. A. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2009.0258 · Cited by 43
Self-citationInfluence of food intake on the bioavailability and efficacy of oral calcitonin
Karsdal, M. A., Byrjalsen, I., Azria, M., Arnold, M., Choi, L., Riis, B. J., & Christiansen, C. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03371.x · Cited by 38
Self-citationTGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression
Tokunaga, T., Mokuda, S., Kohno, H., Yukawa, K., Kuranobu, T., Oi, K., Yoshida, Y., Hirata, S., & Sugiyama, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030800 · Cited by 39
“Several previous studies demonstrated that osteoclasts were differentiated exclusively from CD14+ monocytes and suggested that CD14+ monocytes were the primary source of osteoclast precursors [13,14,52,54,55].”
BackgroundResultTissue-Engineered Model of Human Osteolytic Bone Tumor
Villasante, A., Marturano-Kruik, A., Robinson, S. T., Liu, Z., Guo, X.-D. E., & Vunjak‐Novakovic, G. (2017) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2016.0371 · Cited by 31
“The purified monocytes were cultured for up to 3 weeks in monolayer in the presence of RANKL to induce osteoclastic lineage differentiation.(24) By week 1, the osteoclast markers, TRAP, calcitonin receptor, and cathepsin K, were expressed (Supplementary Fig S3C), and this expression reached the maximum level at week 3.”
MethodHazama, R., Qu, X., Kunio, Y., Tanaka, C., Kinoshita, E., He, J., Takahashi, S., Tohyama, K., Yamamura, H., & Tohyama, Y. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01317.x · Cited by 34
“To develop an in vitro study of osteolysis, CD14-positive monocytes were isolated from human peripheral blood and differentiated under the osteoclast-inducing condition, plated on vitronectin-coated (a ligand of integrin αvβ3) glass-dish or dentin slices (Zou et al. 2007; Sørensen et al. 2007).”
MethodStructural and functional changes in the alveolar bone osteoclasts of estrogen‐treated rats
Faloni, A. P. D. S., Sasso‐Cerri, E., Rocha, F. R. G., Katchburian, E., & Cerri, P. S. (2012) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01449.x · Cited by 31
“According to Sorensen et al. (2007), mature or active multinucleated osteoclasts express MMP-9, whereas mononucleated osteo- clasts precursors do not.”
BackgroundInfluentialKjelgaard-Petersen, C. F., Platt, A., Braddock, M., Jenkins, M. A., Musa, K., Graham, E., Gantzel, T., Slynn, G., Weinblatt, M. E., Karsdal, M. A., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40527 · Cited by 35
“Human osteoclasts were generated from CD14+ monocytes isolated from peripheral blood, as described previously (42).”
MethodSelf-citationA Pharmacokinetic and Pharmacodynamic Comparison of Synthetic and Recombinant Oral Salmon Calcitonin
Karsdal, M. A., Byrjalsen, I., Henriksen, K., Riis, B. J., & Christiansen, C. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008329552 · Cited by 30
Self-citationKatri, A., Dąbrowska, A., Löfvall, H., Karsdal, M. A., Andreassen, K. V., Thudium, C. S., & Henriksen, K. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.05.016 · Cited by 28
Self-citationHase, H., Kanno, Y., Kojima, H., Sakurai, D., & Kobata, T. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23971 · Cited by 26
“The peripheral blood monocyte osteoclast characterization assay was performed according to the method of Sorensen et al (34).”
MethodLiu, Z., Liu, H., Li, Y., Wang, Y., Xing, R., Fu, M., Xiang, C., & Fu, R. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4475 · Cited by 26
IgA Immune Complexes Induce Osteoclast-Mediated Bone Resorption
Breedveld, A. C., van Gool, M. M. J., van Delft, M. A. M., van der Laken, C. J., de Vries, T. J., Jansen, I. D. C., & van Egmond, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651049 · Cited by 29
Greisen, S. R., Einarsson, H. B., Hvid, M., Hauge, E., Deleuran, B. W., & Kragstrup, T. W. (2015) · Apmis · doi:10.1111/apm.12416 · Cited by 24
“(M-CSF) and RANKL has become an established in vitro method for studying osteoclastogenesis (7, 12, 13).”
MethodSurvival, Retention, and Selective Proliferation of Lymphocytes Is Mediated by Gingival Fibroblasts
Moonen, C. G. J., Alders, S. T., Bontkes, H. J., Schoenmaker, T., Nicu, E. A., Loos, B. G., & de Vries, T. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01725 · Cited by 22
“Within PBMCs, the monocytes are the only osteoclast precursor subset as previously demonstrated (13, 14, 28).”
Vu, A. A., Kushram, P., & Bose, S. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01181 · Cited by 19
Human Osteoclast Culture and Phenotypic Characterization
Agrawal, A., Gallagher, J. A., & Gartland, A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-367-7_23 · Cited by 23
Neutzsky-Wulff, A. V., Sørensen, M. G., Kocijancic, D., Leeming, D. J., Dziegiel, M. H., Karsdal, M. A., & Henriksen, K. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-109 · Cited by 22
“[44].”
Self-citationSteroid and xenobiotic receptor-mediated effects of bisphenol A on human osteoblasts
Miki, Y., Hata, S., Nagasaki, S., Suzuki, T., Ito, K., Kumamoto, H., & Sasano, H. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.05.013 · Cited by 24
Overexpression of miRNA-22-3p attenuates osteoporosis by targeting MAPK14
Jia, X., Yang, M., Hu, W., & Cai, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10124 · Cited by 20
Osteoclasts drive bone formation in ectopic and orthotopic environments
Zhang, Y., Yu, T., Xiang, Q., van den Tillaart, F. M., Ma, J., Zhuang, Z., Stessuk, T., Wang, H., & van den Beucken, J. J. J. P. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123377 · Cited by 24
Improved methods for testing antiresorptive compounds in human osteoclast cultures
Rissanen, J. P., Ylipahkala, H., Fagerlund, K. M., Long, C. J., Väänänen, H. K., & Halleen, J. M. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0002-1 · Cited by 19
Thudium, C. S., Moscatelli, I., Löfvall, H., Kertész, Z., Montano, C., Flores, C., Karsdal, M. A., Schulz, A., Richter, J., & Henriksen, K. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0187-6 · Cited by 20
Self-citationModels and screening assays for drug discovery in osteoporosis
Rissanen, J. P., & Halleen, J. M. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.532484 · Cited by 17
“This can be conveniently done using CD14 or CD34 human osteoclast precursor cells derived from peripheral blood or bone marrow [15-18].”
MethodIdentification of the calcitonin receptor in osteoarthritic chondrocytes
Segovia‐Silvestre, T., Bonnefond, C., Sondergaard, B. C., Christensen, T., Karsdal, M. A., & Bay‐Jensen, A. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-407 · Cited by 16
“band in human osteoclasts and chondrocytes OCL: 10 μg and 20 μg protein of in vitro differentiated human osteoclasts lysates [34]; CHO1: 30”
Self-citationZhang, H., Ding, W., Ji, F., & Wu, D. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7996 · Cited by 16
“CD 14+ peripheral blood mononuclear cells (PBMCs) are precursors of osteoclasts and are associated with the pathogenesis of osteoporosis (6,7).”
Kim, T., Lee, B., Kwon, E., Choi, C. H., Sung, I., Kim, Y.-J., Sohn, J., & Ji, J. D. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.09.011 · Cited by 17
Markers of Bone and Cartilage Turnover
Woitge, H. W., & Seibel, M. J. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-106438 · Cited by 16
Schoenmaker, T., Wouters, F., Micha, D., Forouzanfar, T., Netelenbos, J. C., Eekhoff, E. M. W., Bravenboer, N., & de Vries, T. J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27693 · Cited by 18
Yu, Y.-F., Yao, P.-Q., Wang, Z., & Xie, W. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03458-0 · Cited by 17
Blümke, A., Ijeoma, E., Simon, J., Wellington, R., Purwaningrum, M., Doulatov, S. R., Leber, E., Scatena, M., & Giachelli, C. M. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03547-6 · Cited by 16
Löfvall, H., Katri, A., Dąbrowska, A., Karsdal, M. A., Luo, Y., He, Y., Manon‐Jensen, T., Dziegiel, M. H., Bay‐Jensen, A., Thudium, C. S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39803-0 · Cited by 16
Self-citationMoscatelli, I., Almarza, E., Schambach, A., Ricks, D. M., Schulz, A., Herzog, C. D., Henriksen, K., Askmyr, M., Schwartz, J. D., & Richter, J. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.12.009 · Cited by 18
Self-citationMakihira, S., Nikawa, H., Kajiya, M., Kawai, T., Mine, Y., Kosaka, E., Silva, M. J. B., Tobiume, K., & Terada, Y. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.044 · Cited by 13
Kadow‐Romacker, A., Duda, G. N., Bormann, N., Schmidmaier, G., & Wildemann, B. (2013) · Transfusion Medicine and Hemotherapy · doi:10.1159/000356284 · Cited by 14
Du, Y., Yu, Q., Zheng, X., & Wang, S. (2020) · Autoimmunity · doi:10.1080/08916934.2020.1839891 · Cited by 12
A Practical Procedure for the In Vitro Generation of Human Osteoclasts and Their Characterization
Husch, J. F. A., Stessuk, T., den Breejen, C., van den Boom, M., Leeuwenburgh, S. C. G., & van den Beucken, J. J. J. P. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2021.0122 · Cited by 12
“21,22,27,28 Although CD14 + sorting allows for obtaining of a homogeneous monocytic osteoclast precursor population, avoiding this step makes the method more practical, cheaper, 20,29 and more gentle to cells.”
InfluentialWookey, P. J., Zulli, A., Lo, C. Y., Hare, D. L., Schwarer, A. P., Darby, I. A., & Leung, A. Y. H. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_13 · Cited by 16
“2006) in cardiovascular disease (CVD, discussed further below) and osteoclasts (Sorensen et al. 2007) all are derived from monocytes.”
BackgroundSoluble CD14 and fracture risk
Bethel, M., Bůžková, P., Fink, H. A., Robbins, J. A., Cauley, J. A., Lee, J. S., Barzilay, J. I., Jalal, D. I., & Carbone, L. D. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3439-9 · Cited by 11
“In humans, it is produced by both hepatocytes [13] and proteolytic cleavage of membrane-bound CD14 [14] on monocytes and macrophages, which are precursors to mature osteoclasts [15–17].”
BackgroundZhang, X., Zhao, Z., Chen, Y., Han, X., & Jie, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109388 · Cited by 9
Glucocorticoids exert context-dependent effects on cells of the joint in vitro
Madsen, S. H., Andreassen, K. V., Christensen, S. T., Karsdal, M. A., Sverdrup, F. M., Bay‐Jensen, A., & Henriksen, K. (2011) · Steroids · doi:10.1016/j.steroids.2011.07.018 · Cited by 11
Self-citation
Metadata
- Authors
- Sørensen, M. G., Henriksen, K., Schaller, S., Henriksen, D. B., Nielsen, F. C., Dziegiel, M. H., & Karsdal, M. A.
- Affiliations
- Nordic Bioscience (Denmark) (DK)
- Copenhagen University Hospital (DK)
- Corresponding author
- Karsdal, Morten Asser
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2006-12-26
- Volume
- 25
- Issue
- 1
- Pages
- 36-45
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W2094539147
- Cited by
- 143
- References
- 71
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- osteoclasts, osteoclastogenesis, CD14+ monocytes, bone resorption, RANKL, macrophage colony-stimulating factor, osteoclast precursors, cathepsin K, tartrate-resistant acid phosphatase, MMP-9, resorption lacunae, lysosomal acidification, antiresorptive agents, C-terminal telopeptide of type I collagen
- MeSH terms
- Animals, Blood, Cattle, Cell Differentiation, Female, Humans, Monocytes, Osteoclasts, Lipopolysaccharide Receptors, Microarray Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.